AlembicPharmaceuticals gets USFDA nod for ophthalmic solution

Drug firm Alembic Pharmaceuticals Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic solution, used to treat allergic conjunctivitis.

For more information on stock tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co


Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research

Posted in: Indian Market Tips